In the targeted therapy of cancer, regulators such as hexokinase 2 (HK2), pyruvate kinase M2 (PKM2), enolase 1 (ENO1), and lactate dehydrogenase A (LDHA) are crucial for the glycolytic pathway. The gene discussed is HK2; the disease is cancer.